Article
Risk for Appendicitis, Cholecystitis, or Diverticulitis in Patients With Psoriasis
- Author:
- Erica B. Lee, BS
- Mina Amin, BS
- Lewei Duan, MS
- Alexander Egeberg, MD, PhD
- Jashin J. Wu, MD
Psoriasis patients may be at an increased risk for gastrointestinal comorbidities including appendicitis, cholecystitis, or diverticulitis. The...
Article
Emerging Therapies In Psoriasis: A Systematic Review
- Author:
- Erica B. Lee, BS
- Mina Amin, BS
- Tina Bhutani, MD
- Jashin J. Wu, MD
Many new biologics are being studied for use in psoriasis. In this review, we evaluate and summarize findings about emerging biologic therapies...
Article
Do Psoriasis Patients Engage In Vigorous Physical Activity?
- Author:
- Mina Amin, BS
- Erica B. Lee, BS
- Tina Bhutani, MD
- Jashin J. Wu, MD
Psoriasis is associated with cardiovascular risk factors and myocardial infarction, but regular physical activity is known to decrease the risk of...
Article
Adalimumab for Hidradenitis Suppurativa
- Author:
- Daniel J. No, BA
- Mina Amin, BS
- Jashin J. Wu, MD
We applaud Kimball et al1 on their report that adalimumab demonstrated clinical improvement in patients with hidradenitis suppurativa (...
Article
BSA75, BSA90, and BSA100: New Clinical Tools for Measuring Improvement in Psoriasis
- Author:
- Jashin J. Wu, MD
- Daniel J. No, BA
- Mina Amin, BS
Currently, there is no widely accepted tool for assessing the severity of psoriasis in the clinical setting.1-5 Moreover, there is still a need...
Article
The Role of Biologic Therapy for Psoriasis in Cardiovascular Risk Reduction
- Author:
- Daniel J. No, BA
- Mina Amin, BS
- Alexander Egeberg, MD, PhD
- Jashin J. Wu, MD
The cardiovascular comorbidities associated with psoriasis have been well documented; however, the mechanism by which psoriasis increases the risk...